Seyed Aria Nejadghaderi

FULL-NAME:               Seyed Aria Nejadghaderi

E-MAIL:                      [email protected]

[email protected]

[email protected]

Address:                    HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

GRADUATE AND POSTGRADUATE

• 2016 – 2023: Medical Doctor (M.D.), School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• 2021- 2023: Master of Public Health (MPH), School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• 2021- 2023: Master of Health Professions Education (MHPE), Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• 2021- 2023: Geriatric research diploma, Tehran University of Medical Sciences, Tehran, Iran

UNDERGRADUATE

• 2015 – 2016: Pre-university course in Biology, National Organization for Development of Exceptional Talents (NODET), Rafsanjan, Iran


• 2012 – 2015: High school diploma in Biology, National Organization for Development of Exceptional Talents (NODET), Rafsanjan, Iran

·        Postdoctoral Research Fellow, HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran, April 2024- Present

• Research assistant, Non-Communicable Disease Research Center (NCDRC), Endocrinology and metabolism population sciences institute, Tehran University of Medical Sciences, Tehran, Iran, May 2019 – Present


• Research assistant, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran, March 2021 – Present


• Researcher, Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran, October 2019 - Present


• Researcher, Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran, March 2020 – Present


• Global Burden of Disease (GBD) Collaborator, Institute for Health Metrics and Evaluation (IHME), University of Washington, WA, USA, May 2021 – Present


• Research Mentor, MSRC Research Academy, Medial Student Research Committee, Iran University of Medical Sciences, Tehran, Iran, October - November 2020  


• Member of the executive committee, 1^st National Conference of Blood-Borne Infections Management and Control, October 2018, Mashhad, Iran


• Participating in “Roban Ghermez” campaign, an awareness campaign for HIV/AIDS, Iranian’s medical students’ association (IMSA)-IFMSA, December 2018, Tehran, Iran


• Participating in a campaign for increasing public awareness about air pollution, Iranian’s medical students’ association (IMSA)- member of IFMSA in Iran, January 2019, Tehran, Iran


• Editorial Board Membership:




• PLOS ONE


• European Journal of Medical Research


• BMC Public Health




• Peer reviewing for the following journals:




• The Lancet Global Health 


• BMC Emergency Medicine


• BMC Infectious Diseases


• BMC Public Health


• Scientific Reports 


• Risk Management and Healthcare Policy journals


• Frontiers in Public Health


• Journal of Hematology and Oncology


• Medical Hypotheses


• PLOS ONE


• Frontiers in Cardiovascular Medicine


• Postgraduate Medicine


• Revista Panamericana de Salud Publica/Pan American Journal of Public Health


• Biomarkers in Medicine


• Ecotoxicology and Environmental Safety


• Heliyon

• Rank 94 in Iranian university entrance exam in natural sciences field among more than 500,000 participants, 2016


• Member of the National Organization for Development of Exceptional Talents (NODET) of Iran

• Public health


• Epidemiology


• Non-communicable diseases


• Cancer epidemiology


• Infectious diseases

• Introduction to Excel software workshop, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, May 2020


• USERN Workshop, Basic R, Children's Medical Center, August 2019


• USERN Workshop, Advanced R, Children's Medical Center, August 2019


• USERN Workshop, Advanced Statistics, Children's Medical Center, August 2019


• USERN Workshop, Scientific Research and Methodology, Children's Medical Center, September 2018


• USERN Workshop, Scientific Writing, Children's Medical Center, September 2018


• USERN Workshop, Basic Data Analysis in SPSS, Tehran University of Medical Sciences (TUMS), September 2018


• USERN Workshop, Systematic Review and Meta-analysis, Tehran University of Medical Sciences (TUMS), September 2018


• USERN Workshop, Submission and Peer Reviewing of Assignments, Children's Medical Center, September 2018


• USERN Workshop, Publishing Academic Book with International Publishers, Children's Medical Center, September 2018


• Elementary Photoshop training course, The University of Tehran, May 2018


• Search strategy workshop, Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, October 2018


• Endnote software workshop, Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, October 2018


• Statistical skills:




• Statistical software: SPSS (basic level)




• Computer skills:




• Being familiar with graphical software: Adobe Photoshop (basic level)


• Other: Microsoft Office (Advanced level), Review Manager (basic level), R programming (basic level), STATA (basic level)

• Outside interests: Jogging and Reading

1. Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed. 2020;91(3):e2020018. Published 2020 Sep 7. doi:10.23750/abm.v91i3.9718


2. Zangiabadian, M., Nejadghaderi, S. A., Mirsaeidi, M., Hajikhani, B., Goudarzi, M., Goudarzi, H., Mardani, M., & Nasiri, M. J. (2020). Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis. Scientific reports, 10(1), 20656. https://doi.org/10.1038/s41598-020-77679-7


3. Nejadghaderi SA, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H. Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy. Med Hypotheses. 2021 Feb;147:110476. doi: 10.1016/j.mehy.2020.110476. Epub 2020 Dec 31. PMID: 33482620; PMCID: PMC7774521.


4. Nejadghaderi SA, Safiri S. The dilemma of herd immunity for COVID-19. J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26768. Epub ahead of print. PMID: 33386744.


5. Nejadghaderi SA, Saghazadeh A, Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? Int J Health Serv. 2021 Mar 9:20731421993940. doi: 10.1177/0020731421993940. Epub ahead of print. PMID: 33686893.


6. Hosseinpour, M., Maleki, F., Khoramdad, M., Sullman, M., Nejadghaderi, S. A., Kolahi, A. A., & Safiri, S. (2021). A systematic literature review of observational studies of the bilateral association between diabetes and migraines. Diabetes & Metabolic Syndrome: Clinical Research & Reviews.


7. Zangiabadian, M., Nejadghaderi, S. A., Zahmatkesh, M. M., Hajikhani, B., Mirsaeidi, M., & Nasiri, M. J. (2021). The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review. Frontiers in Endocrinology, 12, 263.


8. Movahed, S. M. M., Akhavizadegan, H., Dolatkhani, F., Nejadghaderi, S. A., Aghajani, F., Gangi, M. F., ... & Ghasemi, H. (2021). Different incidences of acute kidney injury (AKI) and outcomes in COVID‐19 patients with and without non‐azithromycin antibiotics: a retrospective study. Journal of medical virology.


9. Noori M, Nejadghaderi SA, Rezaei N. "Original Antigenic Sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants. Infect Control Hosp Epidemiol. 2021 May 3:1-6. doi: 10.1017/ice.2021.199. Epub ahead of print. PMID: 33938416.


10. Balibegloo M, Nejadghaderi SA, Sadeghalvad M, Soleymanitabar A, Nezamabadi SS, Saghazadeh A, Rezaei N. Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis. International Immunopharmacology. 2021 Jul 1;96:107796.


11. Shokri P, Golmohammadi S, Noori M, Nejadghaderi SA, Carson‐Chahhoud K, Safiri S. The relationship between blood groups and risk of infection with SARS‐CoV‐2 or development of severe outcomes: A review.


12. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Kolahi AA, Safiri S. Epidemiology, prognosis and management of potassium disorders in Covid-19. Rev Med Virol. 2021 Jun 2:e2262. doi: 10.1002/rmv.2262. Epub ahead of print. PMID: 34077995.


13. Shaafi S, Hadisi F, Mahmoudinezhad M, Razmi H, Nejadghaderi SA, Khalili M. The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study. BMC Neurol. 2021 Jul 2;21(1):258. doi: 10.1186/s12883-021-02257-x. PMID: 34215195; PMCID: PMC8252289.


14. Noori M, Nejadghaderi SA, Arshi S, Carson-Chahhoud K, Ansarin K, Kolahi AA, Safiri S. Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies. Rev Med Virol. 2021 Jul 19:e2277. doi: 10.1002/rmv.2277. Epub ahead of print. PMID: 34286893.


15. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Ardalan M, Kolahi AA, Safiri S. How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels? Mol Biol Rep. 2021 Aug 15:1–7. doi: 10.1007/s11033-021-06642-0. Epub ahead of print. PMID: 34392451; PMCID: PMC8364628.


16. Safiri S, Kolahi AA, Noori M, Nejadghaderi SA, Karamzad N, Bragazzi NL, Sullman MJM, Abdollahi M, Collins GS, Kaufman JS, Grieger JA. Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. J Hematol Oncol. 2021 Nov 4;14(1):185. doi: 10.1186/s13045-021-01202-2. PMID: 34736513; PMCID: PMC8567696.


17. Bragazzi NL, Kolahi AA, Nejadghaderi SA, Lochner P, Brigo F, Naldi A, Lanteri P, Garbarino S, Sullman MJM, Dai H, Wu J, Kong JD, Jahrami H, Sohrabi MR, Safiri S. Global, regional, and national burden of Guillain-Barré syndrome and its underlying causes from 1990 to 2019. J Neuroinflammation. 2021 Nov 11;18(1):264. doi: 10.1186/s12974-021-02319-4. PMID: 34763713; PMCID: PMC8581128.


18. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Ardalan M, Kolahi AA, Safiri S. A Review on the Possible Pathophysiology of Potassium Abnormalities in COVID-19. Iran J Kidney Dis. 2021 Dec;15(6):397-407. PMID: 34930851.


19. Fazlollahi A, Zahmatyar M, Noori M, Nejadghaderi SA, Sullman MJM, Shekarriz-Foumani R, Kolahi AA, Singh K, Safiri S. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol. 2021 Dec 17:e2318. doi: 10.1002/rmv.2318. Epub ahead of print. PMID: 34921468.


20. Kazeminasab S, Nejadghaderi SA, Amiri P, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Neck pain: global epidemiology, trends and risk factors. BMC Musculoskelet Disord. 2022 Jan 3;23(1):26. doi: 10.1186/s12891-021-04957-4. PMID: 34980079; PMCID: PMC8725362.


21. Ahmadzad-Asl M, Davoudi F, Mohamadi S, Hadi F, Nejadghaderi SA, Mirbehbahani SH, Jabbarinejad R, Saneh S, Arshadi M, Naserbakht M, Sinyor M, Kabir A, Shamshiri A. Systematic review and meta-analysis of the placebo effect in panic disorder: Implications for research and clinical practice. Aust N Z J Psychiatry. 2022 Jan 7:48674211068793. doi: 10.1177/00048674211068793. Epub ahead of print. PMID: 34996304.


22. Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-Chahhoud K, Kolahi AA, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol. 2022 Jan 20;12:785946. doi: 10.3389/fimmu.2021.785946. PMID: 35126355; PMCID: PMC8815083.


23. Safiri S, Carson-Chahhoud K, Karamzad N, Sullman MJM, Nejadghaderi SA, Taghizadieh A, Bell AW, Kolahi AA, Ansarin K, Mansournia MA, Collins GS, Kaufman JS. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. Chest. 2022 Feb;161(2):318-329. doi: 10.1016/j.chest.2021.09.042. Epub 2021 Oct 23. PMID: 34699773.


24. Safiri S, Karamzad N, Kaufman JS, Nejadghaderi SA, Bragazzi NL, Sullman MJM, Almasi-Hashiani A, Mansournia MA, Collins GS, Kolahi AA, Jemal A. Global, regional, and national burden of cancers attributable to excess body weight in 204 countries and territories, 1990 to 2019. Obesity (Silver Spring). 2022 Feb;30(2):535-545. doi: 10.1002/oby.23355. Epub 2022 Jan 18. PMID: 35041300.


25. Jaberinezhad M, Farhoudi M, Nejadghaderi SA, Alizadeh M, Sullman MJM, Carson-Chahhoud K, Collins GS, Safiri S. The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Feb 17;12(1):2700. doi: 10.1038/s41598-022-06418-x. PMID: 35177688; PMCID: PMC8854638.


26. Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022 Feb 23;12:800605. doi: 10.3389/fneur.2021.800605. PMID: 35281991; PMCID: PMC8904749.


27. Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJM, Moradi-Lakeh M, Collins G, Kolahi AA. Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019. Front Endocrinol (Lausanne). 2022 Feb 25;13:838027. doi: 10.3389/fendo.2022.838027. PMID: 35282442; PMCID: PMC8915203.


28. Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi SA, Almasi-Hashiani A, Sullman MJM, Mansournia MA, Bragazzi NL, Kaufman JS, Collins GS, Kolahi AA. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019. Eur J Prev Cardiol. 2022 Mar 11;29(2):420-431. doi: 10.1093/eurjpc/zwab213. PMID: 34922374.


29. Nejadghaderi SA, Roshani S, Mohammadi E, Yoosefi M, Rezaei N, Esfahani Z, Azadnajafabad S, Ahmadi N, Shahin S, Kazemi A, Namazi Shabestari A, Khosravi A, Mokdad AH, Larijani B, Farzadfar F. The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019. PLoS One. 2022 Apr 21;17(4):e0263403. doi: 10.1371/journal.pone.0263403. PMID: 35446852; PMCID: PMC9022854.


30. Motlagh Asghari K, Nejadghaderi SA, Alizadeh M, Sanaie S, Sullman MJM, Kolahi AA, Avery J, Safiri S. Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Apr 29;12(1):7039. doi: 10.1038/s41598-022-11006-0. PMID: 35488014; PMCID: PMC9052181.


31. Noori M, Shokri P, Nejadghaderi SA, Golmohammadi S, Carson-Chahhoud K, Bragazzi NL, Ansarin K, Kolahi AA, Arshi S, Safiri S. ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta-analysis. Rev Med Virol. 2022 May;32(3):e2298. doi: 10.1002/rmv.2298. Epub 2021 Sep 30. PMID: 34590759.


32. Safiri S, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Bragazzi NL, Sullman MJM, Almasi-Hashiani A, Mansournia MA, Collins GS, Kaufman JS, Kolahi AA. Global, regional, and national cancer deaths and disability-adjusted life-years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990-2019. Cancer. 2022 May 1;128(9):1840-1852. doi: 10.1002/cncr.34111. Epub 2022 Mar 3. PMID: 35239973.


33. Sadeghalvad M, Mansourabadi AH, Noori M, Nejadghaderi SA, Masoomikarimi M, Alimohammadi M, Rezaei N. Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies. Rev Med Virol. 2022 May 1:e2359. doi: 10.1002/rmv.2359. Epub ahead of print. PMID: 35491495.


34. Safiri S, Noori M, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Sullman MJM, Collins GS, Kolahi AA, Avery J. Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019. Hum Reprod. 2022 May 19:deac091. doi: 10.1093/humrep/deac091. Epub ahead of print. PMID: 35586937.


35. Shaafi S, Bonakdari E, Sadeghpour Y, Nejadghaderi SA. Correlation between red blood cell distribution width, neutrophil to lymphocyte ratio, and neutrophil to platelet ratio with 3-month prognosis of patients with intracerebral hemorrhage: a retrospective study. BMC Neurol. 2022 May 24;22(1):191. doi: 10.1186/s12883-022-02721-2. PMID: 35610607; PMCID: PMC9128218.


36. Safiri S, Nejadghaderi SA, Abdollahi M, Carson-Chahhoud K, Kaufman JS, Bragazzi NL, Moradi-Lakeh M, Mansournia MA, Sullman MJM, Almasi-Hashiani A, Taghizadieh A, Collins GS, Kolahi AA. Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019. Cancer Med. 2022 May 27. doi: 10.1002/cam4.4647. Epub ahead of print. PMID: 35621231.


37. GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022 Jun 20:S2468-1253(22)00124-8. doi: 10.1016/S2468-1253(22)00124-8. Epub ahead of print. PMID: 35738290.


38. GBD 2019 Iran Collaborators. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Apr 23;399(10335):1625-1645. doi: 10.1016/S0140-6736(21)02751-3. Epub 2022 Apr 6. PMID: 35397236; PMCID: PMC9023870.


39. GBD 2019 Adolescent Young Adult Cancer Collaborators. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022 Jan;23(1):27-52. doi: 10.1016/S1470-2045(21)00581-7. Epub 2021 Dec 3. PMID: 34871551; PMCID: PMC8716339.


40. Safiri S, Kolahi AA, Naghavi M; Global Burden of Disease Bladder Cancer Collaborators. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. BMJ Glob Health. 2021 Nov;6(11):e004128. doi: 10.1136/bmjgh-2020-004128. PMID: 34844997; PMCID: PMC8634015.


41. GBD 2019 Adolescent Transport and Unintentional Injuries Collaborators. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. 2022 Jun 29:S2468-2667(22)00134-7. doi: 10.1016/S2468-2667(22)00134-7. Epub ahead of print. PMID: 35779567.


42. Shamekh A, Alizadeh M, Nejadghaderi SA, Sullman MJM, Kaufman JS, Collins GS, Kolahi A-A and Safiri S (2022) The Burden of Osteoarthritis in the Middle East and North Africa Region From 1990 to 2019. Front. Med. 9:881391. doi: 10.3389/fmed.2022.881391


43. Noori M, Azizi S, Abbasi Varaki F, Nejadghaderi SA, Bashash D. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies. Int Immunopharmacol. 2022 Sep;110:109046. doi: 10.1016/j.intimp.2022.109046. Epub 2022 Jul 12. PMID: 35843148; PMCID: PMC9273573.


44. Rezaei Tolzali MM, Noori M, Shokri P, Rahmani S, Khanzadeh S, Nejadghaderi SA, Fazlollahi A, Sullman MJM, Singh K, Kolahi AA, Arshi S, Safiri S. Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review. Rev Med Virol. 2022 Aug 27:e2388. doi: 10.1002/rmv.2388. Epub ahead of print. PMID: 36029180; PMCID: PMC9539231.


45. Nejadghaderi SA, Moghaddam SS, Azadnajafabad S, Rezaei N, Rezaei N, Tavangar SM, Jamshidi H, Mokdad AH, Naghavi M, Farzadfar F, Larijani B. Burden of thyroid cancer in North Africa and Middle East 1990-2019. Front Oncol. 2022 Sep 23;12:955358. doi: 10.3389/fonc.2022.955358. PMID: 36212501; PMCID: PMC9538696.


46. Zangiabadian M, Golmohammadi S, Nejadghaderi SA, Zahmatkesh MM, Nasiri MJ, Sadeghian M. The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis. Front Psychiatry. 2022 Sep 26;13:1003257. doi: 10.3389/fpsyt.2022.1003257. PMID: 36226100; PMCID: PMC9548642.


47. Fazlollahi A, Zahmatyar M, Alizadeh H, Noori M, Jafari N, Nejadghaderi SA, Sullman MJM, Gharagozli K, Kolahi AA, Safiri S. Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis. BMC Neurol. 2022 Oct 11;22(1):383. doi: 10.1186/s12883-022-02874-0. PMID: 36221048; PMCID: PMC9552480.


48. Araj-Khodaei M, Sanaie S, Nejadghaderi SA, Sullman MJM, Samei-Sis S, Taheri-Targhi S, Yousefi Z, Matlabi H, Safiri S, Azizi-Zeinalhajlou A. Profile of Tabriz Older People Health Survey (TOPS-2019): a representative community-based cross-sectional study. Sci Rep. 2022 Oct 25;12(1):17879. doi: 10.1038/s41598-022-22710-2. PMID: 36284173; PMCID: PMC9596475.


49. Safiri S, Noori M, Nejadghaderi SA, Shamekh A, Karamzad N, Sullman MJM, Grieger JA, Collins GS, Abdollahi M, Kolahi AA. The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019. Int J Eat Disord. 2022 Oct 27. doi: 10.1002/eat.23835. Epub ahead of print. PMID: 36301044.


50. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Aug 20;400(10352):563-591. doi: 10.1016/S0140-6736(22)01438-6. PMID: 35988567.


51. GBD 2019 LRI Collaborators. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis. 2022 Aug 11:S1473-3099(22)00510-2. doi: 10.1016/S1473-3099(22)00510-2. Epub ahead of print. PMID: 35964613.


52. Azangou-Khyavy M, Saeedi Moghaddam S, Rezaei N, Esfahani Z, Rezaei N, Azadnajafabad S, Rashidi MM, Mohammadi E; GBD 2019 Iran Thyroid Cancer Collaborators, Tavangar SM, Jamshidi H, Mokdad AH, Naghavi M, Farzadfar F, Larijani B. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. Sci Rep. 2022 Aug 2;12(1):13231. doi: 10.1038/s41598-022-17115-0. PMID: 35918489; PMCID: PMC9346133.


53. Safiri S, Kolahi AA, Noori M, Nejadghaderi SA, Aslani A, Sullman MJM, Farhoudi M, Araj-Khodaei M, Collins GS, Kaufman JS, Gharagozli K. Correction: Burden of tension-type headache in the Middle East and North Africa region, 1990-2019. J Headache Pain. 2022 Aug 2;23(1):94. doi: 10.1186/s10194-022-01454-4. Erratum for: J Headache Pain. 2022 Jul 6;23(1):77. PMID: 35915407; PMCID: PMC9344607.


54. Abbasi-Kangevari M, Saeedi Moghaddam S, Ghamari SH, Azangou-Khyavy M, Malekpour MR, Rezaei N, Rezaei N, Kolahi AA; GBD 2019 NAME Prostate Cancer Collaborators, Amini E, Mokdad AH, Jamshidi H, Naghavi M, Larijani B, Farzadfar F. The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study. Front Oncol. 2022 Sep 13;12:961086. doi: 10.3389/fonc.2022.961086. PMID: 36176394; PMCID: PMC9513750.


55. Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carson-Chahhoud K, Bragazzi NL, Sullman MJM, Beyranvand MR, Mansournia MA, Almasi-Hashiani A, Collins GS, Kolahi AA. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019. Front Endocrinol (Lausanne). 2022 Jul 19;13:879890. doi: 10.3389/fendo.2022.879890. PMID: 35966097; PMCID: PMC9366927.


56. Jalalvand, D., Akbari, F., Pirsalehi, A., Dehghan, P., Nejadghaderi, S., Jaliliankhave, L., Hasanzadeh, T., Sanadgol, G., Shirini, D., Eslami, Z. (2022). Clinical, Laboratory, and Chest CT Scan Prognostic Factors for COVID-19 Mortality Cases. Trauma Monthly, 27(Especial Issue (COVID-19 and Emergency Medicine)), 54-67. doi: 10.30491/tm.2021.310669.1386


57. Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Ahmadian Heris J, Ansarin K, Mansournia MA, Collins GS, Kolahi AA, Kaufman JS. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679. PMID: 35896191; PMCID: PMC9326843.


58. Nejadghaderi SA, Balibegloo M, Saghazadeh A, Rezaei N. Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review. PLoS One. 2022 Jul 18;17(7):e0271506. doi: 10.1371/journal.pone.0271506. PMID: 35849585; PMCID: PMC9292075.


59. GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022 Jul 16;400(10347):185-235. doi: 10.1016/S0140-6736(22)00847-9. Erratum in: Lancet. 2022 Jul 30;400(10349):358. PMID: 35843246; PMCID: PMC9289789.


60. Mohamadi S, Ahmadzad-Asl M, Nejadghaderi SA, Jabbarinejad R, Mirbehbahani SH, Sinyor M, Richter MA, Davoudi F. Systematic Review and Meta-Analysis of the Placebo Effect and its Correlates in Obsessive Compulsive Disorder. Can J Psychiatry. 2022 Jul 25:7067437221115029. doi: 10.1177/07067437221115029. Epub ahead of print. PMID: 35876317.


61. Safiri S, Noori M, Nejadghaderi SA, Sullman MJM, Bragazzi NL, Almasi-Hashiani A, Mansournia MA, Kolahi AA. Burden of female breast cancer in the Middle East and North Africa region, 1990-2019. Arch Public Health. 2022 Jul 11;80(1):168. doi: 10.1186/s13690-022-00918-y. PMID: 35818086; PMCID: PMC9272597.


62. Rezaee M, Esfahani Z, Nejadghaderi SA, Abbasi-Kangevari M, Saeedi Moghaddam S, Ghanbari A, Ghamari A, Golestani A, Foroutan Mehr E, Kazemi A, Haghshenas R, Moradi M, Kompani F, Rezaei N, Larijani B. Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. Environ Health. 2022 Oct 29;21(1):105. doi: 10.1186/s12940-022-00914-3. PMID: 36309664; PMCID: PMC9617306.


63. Abolghasemi M, Ali Ashrafi S, Asadi M, Shanehbandi D, Sadigh Etehad S, Poursaei E, Nejadghaderi SA, Shaafi S. MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose. Mol Biol Rep. 2022 Nov 1. doi: 10.1007/s11033-022-07905-0. Epub ahead of print. PMID: 36319782.


64. Ali Ashrafi S, Asadi M, Shanehbandi D, Sadigh Eteghad S, Fazlollahi A, Nejadghaderi SA, Shaafi S. Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study. BMC Neurol. 2022 Nov 3;22(1):405. doi: 10.1186/s12883-022-02909-6. PMID: 36329419; PMCID: PMC9632146.


65. Mousavi SE, Nejadghaderi SA, Khabbazi A, Alizadeh M, Sullman MJM, Kaufman JS, Collins GS, Safiri S. The burden of rheumatoid arthritis in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Nov 11;12(1):19297. doi: 10.1038/s41598-022-22310-0. PMID: 36369238; PMCID: PMC9652423.


66. Safiri S, Nejadghaderi SA, Noori M, Sullman MJM, Collins GS, Kaufman JS, Kolahi AA. Burden of diseases and injuries attributable to alcohol consumption in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Nov 11;12(1):19301. doi: 10.1038/s41598-022-22901-x. PMID: 36369336; PMCID: PMC9652338.


67. Feizi H, Alizadeh M, Nejadghaderi SA, Noori M, Sullman MJM, Ahmadian Heris J, Kolahi AA, Collins GS, Safiri S. The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019. Respir Res. 2022 Nov 19;23(1):319. doi: 10.1186/s12931-022-02242-z. PMID: 36403049; PMCID: PMC9675283.


68. Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Karamzad N, Sullman MJM, Pirotta S, Collins GS, Abdollahi M, Kolahi AA. Comparison of the burden of anorexia nervosa in the Middle East and North Africa region between 1990 and 2019. J Eat Disord. 2022 Dec 10;10(1):192. doi: 10.1186/s40337-022-00718-3. PMID: 36496474; PMCID: PMC9738022.


69. Ghasemi H, Kazemian S, Nejadghaderi SA, Shafie M. Takotsubo syndrome and COVID-19: A systematic review. Health Sci Rep. 2022 Dec 2;6(1):e972. doi: 10.1002/hsr2.972. PMID: 36479387; PMCID: PMC9718950.


70. GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2023 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21. PMID: 36423648.


71. Amiri F, Kolahi AA, Nejadghaderi SA, Noori M, Khabbazi A, Sullman MJM, Kaufman JS, Collins GS, Safiri S. The Burden of Gout and Its Attributable Risk Factors in the Middle East and North Africa Region, 1990 to 2019. J Rheumatol. 2022 Sep 1:jrheum.220425. doi: 10.3899/jrheum.220425. Epub ahead of print. PMID: 36455948.


72. Ashrafi-Asgarabad A, Bokaie S, Razmyar J, Akbarein H, Nejadghaderi SA, Carson-Chahhoud K, Sullman MJM, Kaufman JS, Safiri S. The burden of lower respiratory infections and their underlying etiologies in the Middle East and North Africa region, 1990-2019: results from the Global Burden of Disease Study 2019. BMC Pulm Med. 2023 Jan 4;23(1):2. doi: 10.1186/s12890-022-02301-7. PMID: 36600241; PMCID: PMC9811697.


73. Nejadghaderi SA, Ahmadi N, Rashidi MM, Ghanbari A, Noori M, Abbasi-Kangevari M, Nasserinejad M, Rezaei N, Yoosefi M, Fattahi N, Ghasemi E, Farzi Y, Abdolhamidi E, Darman M, Djalalinia S, Farzadfar F. Physical activity pattern in Iran: Findings from STEPS 2021. Front Public Health. 2023 Jan 4;10:1036219. doi: 10.3389/fpubh.2022.1036219. PMID: 36684955; PMCID: PMC9846211.


74. Safiri S, Mahmoodpoor A, Kolahi AA, Nejadghaderi SA, Sullman MJM, Mansournia MA, Ansarin K, Collins GS, Kaufman JS, Abdollahi M. Global burden of lower respiratory infections during the last three decades. Front Public Health. 2023 Jan 9;10:1028525. doi: 10.3389/fpubh.2022.1028525. PMID: 36699876; PMCID: PMC9869262.


75. Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Singh K, Kolahi AA, Gharagozli K. The burden of Parkinson's disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019. BMC Public Health. 2023 Jan 16;23(1):107. doi: 10.1186/s12889-023-15018-x. PMID: 36642724; PMCID: PMC9841703.


76. Safiri S, Nejadghaderi SA, Noori M, Sullman MJM, Collins GS, Kaufman JS, Hill CL, Kolahi AA. The burden of low back pain and its association with socio-demographic variables in the Middle East and North Africa region, 1990-2019. BMC Musculoskelet Disord. 2023 Jan 23;24(1):59. doi: 10.1186/s12891-023-06178-3. PMID: 36683025; PMCID: PMC9869505.


77. Nejadghaderi SA, Balibegloo M, Noori M, Fayyaz F, Saghazadeh A, Rezaei N. Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis. Expert Rev Anticancer Ther. 2023 Mar;23(3):307-318. doi: 10.1080/14737140.2023.2183847. Epub 2023 Mar 1. PMID: 36856069.


78. Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Collins GS, Kolahi AA, Gharagozli K. The burden of Alzheimer's disease and other types of dementia in the Middle East and North Africa region, 1990-2019. Age Ageing. 2023 Mar 1;52(3):afad042. doi: 10.1093/ageing/afad042. PMID: 36995136.


79. Tondro Anamag F, Noori M, Nejadghaderi SA, Sullman MJM, Grieger JA, Kolahi AA, Safiri S. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019. Cancer Med. 2023 Apr;12(8):10031-10044. doi: 10.1002/cam4.5743. Epub 2023 Mar 23. PMID: 36951550; PMCID: PMC10166946.


80. Fazlollahi A, Zahmatyar M, ZareDini M, Golabi B, Nejadghaderi SA, Sullman MJM, Gharagozli K, Kolahi AA, Safiri S. Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023 Apr 3;6(4):e239126. doi: 10.1001/jamanetworkopen.2023.9126. PMID: 37079302; PMCID: PMC10119734.

81.  Nejadghaderi SA, Kolahi AA, Noori M, Sullman MJM, Safiri S. The burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa region, 1990-2019. J Gastroenterol Hepatol. 2023 May 23. doi: 10.1111/jgh.16217. Epub ahead of print. PMID: 37218385

82.  Nejadghaderi, Seyed Aria, et al. "Immune Checkpoint Inhibition for Pancreatic Cancer." ACTA MEDICA IRANICA (2023).

83.  Nejadghaderi SA, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Rezaei N, Rezaei N, Naghavi M, Larijani B, Farzadfar F. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019. Front Endocrinol (Lausanne). 2023 Feb 27;14:1115833. doi: 10.3389/fendo.2023.1115833. PMID: 36923218; PMCID: PMC10010168.

84.  Ammar A, Trabelsi K, Hermassi S, Kolahi AA, Mansournia MA, Jahrami H, Boukhris O, Boujelbane MA, Glenn JM, Clark CCT, Nejadghaderi A, Puce L, Safiri S, Chtourou H, Schöllhorn WI, Zmijewski P, Bragazzi NL. Global disease burden attributed to low physical activity in 204 countries and territories from 1990 to 2019: Insights from the Global Burden of Disease 2019 Study. Biol Sport. 2023 Jul;40(3):835-855. doi: 10.5114/biolsport.2023.121322. Epub 2022 Nov 22. PMID: 37398951; PMCID: PMC10286621.

85.  Malekpour MR, Abbasi-Kangevari M, Ghamari SH, Khanali J, Heidari-Foroozan M, Moghaddam SS, Azangou-Khyavy M, Rezazadeh-Khadem S, Rezaei N, Shobeiri P, Esfahani Z, Rezaei N; GBD 2019 North Africa and the Middle East MRF Collaborators; Mokdad AH, Naghavi M, Larijani B, Farzadfar F. The burden of metabolic risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study. EClinicalMedicine. 2023 Jun 2;60:102022. doi: 10.1016/j.eclinm.2023.102022. PMID: 37287869; PMCID: PMC10242634.

86.  Moradi S, Parsaei A, Saeedi Moghaddam S, Aryannejad A, Azadnajafabad S, Rezaei N, Mashinchi B, Esfahani Z, Shobeiri P, Rezaei N; GBD 2019 Iran MRF Collaborators; Naghavi M, Larijani B, Farzadfar F. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Front Public Health. 2023 Jun 1;11:1149719. doi: 10.3389/fpubh.2023.1149719. PMID: 37325329; PMCID: PMC10268245.

87.  GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 May 22;5(6):e316-e329. doi: 10.1016/S2665-9913(23)00098-X. PMID: 37273833; PMCID: PMC10234592.

88.  GBD 2019 Child and Adolescent Communicable Disease Collaborators. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860-7. Epub ahead of print. PMID: 37393924.

89.  GBD 2019 Asia and All Cancers Collaborators. Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Reg Health Southeast Asia. 2024 Jan 2;21:100333. doi: 10.1016/j.lansea.2023.100333. PMID: 38361599; PMCID: PMC10866992.

90.  Rashidi MM, Saeedi Moghaddam S, Azadnajafabad S, Mohammadi E, Khalaji A, Malekpour MR, Keykhaei M, Rezaei N, Esfahani Z, Rezaei N; GBD 2019 NAME Kidney Dysfunction Risk Factor Collaborators; Mokdad AH, Murray CJL, Naghavi M, Larijani B, Farzadfar F. Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019. Clin Kidney J. 2023 Nov 17;17(1):sfad279. doi: 10.1093/ckj/sfad279. PMID: 38288035; PMCID: PMC10823484.

91.  Mensah GA, Fuster V, Murray CJL, Roth GA; Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol. 2023 Dec 19;82(25):2350-2473. doi: 10.1016/j.jacc.2023.11.007. PMID: 38092509.

92.  Azadnajafabad S, Saeedi Moghaddam S, Mohammadi E, Rezaei N, Rashidi MM, Rezaei N, Mokdad AH, Naghavi M, Murray CJL, Larijani B, Farzadfar F; GBD 2019 NAME Breast Cancer Collaborators. Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Front Oncol. 2023 Aug 1;13:1132816. doi: 10.3389/fonc.2023.1132816. PMID: 37593096; PMCID: PMC10431599.

93.  GBD 2019 Meningitis Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023 Aug;22(8):685-711. doi: 10.1016/S1474-4422(23)00195-3. PMID: 37479374; PMCID: PMC10356620.

94.  GBD 2021 Carbon Monoxide Poisoning Collaborators. Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000-2021: results from the Global Burden of Disease Study 2021. Lancet Public Health. 2023 Nov;8(11):e839-e849. doi: 10.1016/S2468-2667(23)00185-8. Epub 2023 Oct 6. PMID: 37813118; PMCID: PMC10602911.

95.  Safiri S, Mousavi SE, Nejadghaderi SA, Noori M, Sullman MJM, Amiri S, Kolahi AA. The Burden of Attention-Deficit Hyperactivity Disorder (ADHD) in the Middle East and North Africa Region, 1990 to 2019. J Atten Disord. 2023 Jul 25:10870547231187161. doi: 10.1177/10870547231187161. Epub ahead of print. PMID: 37491897.

96.  Zahmatyar M, Fazlollahi A, Motamedi A, Zolfi M, Seyedi F, Nejadghaderi SA, Sullman MJM, Mohammadinasab R, Kolahi AA, Arshi S, Safiri S. Human monkeypox: history, presentations, transmission, epidemiology, diagnosis, treatment, and prevention. Front Med (Lausanne). 2023 Jul 20;10:1157670. doi: 10.3389/fmed.2023.1157670. PMID: 37547598; PMCID: PMC10397518.

97.  Sedaghat Z, Khodakarim S, Nejadghaderi SA, Sabour S. Association between metabolic syndrome and myocardial infarction among patients with excess body weight: a systematic review and meta-analysis. BMC Public Health. 2024 Feb 12;24(1):444. doi: 10.1186/s12889-024-17707-7. PMID: 38347488; PMCID: PMC10863149.

98.  Safiri S, Jaberinezhad M, Mousavi SE, Motlagh Asghari K, Shamekh A, Nejadghaderi SA, Sullman MJM, Houshyar Y, Behrangi E, Kolahi AA. The burden of dermatitis from 1990-2019 in the Middle East and North Africa region. BMC Public Health. 2024 Feb 7;24(1):399. doi: 10.1186/s12889-024-17836-z. PMID: 38326798; PMCID: PMC10848450.

99.  Safiri S, Hassanzadeh K, Janbaz Alamdary S, Mousavi SE, Nejadghaderi SA, Sullman MJM, Naghdi-Sedeh N, Kolahi AA. The burden of testicular cancer from 1990 to 2019 in the Middle East and North Africa region. Front Oncol. 2023 Dec 22;13:1276965. doi: 10.3389/fonc.2023.1276965. PMID: 38188291; PMCID: PMC10767553.

100.                   Daei Sorkhabi A, ZareDini M, Fazlollahi A, Sarkesh A, Naseri A, Mousavi SE, Nejadghaderi SA, Sullman MJM, Kolahi AA, Safiri S. The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials. BMC Pulm Med. 2023 Dec 8;23(1):495. doi: 10.1186/s12890-023-02755-3. PMID: 38066549; PMCID: PMC10704633.

101.                   Safiri S, Mousavi SE, Noori M, Nejadghaderi SA, Sullman MJM, Singh K, Kolahi AA. The burden of rheumatic heart disease in the Middle East and North Africa region, 1990-2019. Arch Cardiovasc Dis. 2023 Dec;116(12):542-554. doi: 10.1016/j.acvd.2023.09.005. Epub 2023 Oct 6. PMID: 37863752.

102.                   Mousavi SE, Ilaghi M, Aslani A, Yekta Z, Nejadghaderi SA. A population-based study on incidence trends of myeloma in the United States over 2000-2020. Sci Rep. 2023 Nov 24;13(1):20705. doi: 10.1038/s41598-023-47906-y. PMID: 38001246; PMCID: PMC10673923.

103.                   Amirkafi A, Mohammadi F, Tehrani-Banihashemi A; GBD Collaborators; Moradi-Lakeh M, Murray CJL, Naghavi M, Mokdad AH. Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings. Soc Psychiatry Psychiatr Epidemiol. 2023 Nov 24. doi: 10.1007/s00127-023-02587-w. Epub ahead of print. PMID: 37999752.

104.                   Nejadghaderi SA, Grieger JA, Karamzad N, Kolahi AA, Sullman MJM, Safiri S, Sabour S. Burden of diseases attributable to excess body weight in the Middle East and North Africa region, 1990-2019. Sci Rep. 2023 Nov 20;13(1):20338. doi: 10.1038/s41598-023-46702-y. PMID: 37990049; PMCID: PMC10663478.

105.                   Nejadghaderi SA, Mousavi SE, Sullman MJM, Kolahi AA, Namazi Shabestari A, Safiri S. The burden of neck pain among adults aged 70 years and older in Iran, 1990-2019. Health Sci Rep. 2023 Nov 8;6(11):e1477. doi: 10.1002/hsr2.1477. PMID: 38028676; PMCID: PMC10630745.

106.                   Ahangar-Sirous R, Alizadeh M, Nejadghaderi SA, Noori M, Khabbazi A, Sullman MJM, Kolahi AA, Collins GS, Safiri S. The burden of neck pain in the Middle East and North Africa region, 1990-2019. Heliyon. 2023 Oct 21;9(11):e21296. doi: 10.1016/j.heliyon.2023.e21296. PMID: 38027849; PMCID: PMC10643100.

107.                   Marghoub S, Sanaie S, Sullman MJM, Nejadghaderi SA, Safiri S, Mohammadinasab R. Obesity from a sign of being rich to a disease of the new age: A historical review. Health Sci Rep. 2023 Nov 1;6(11):e1670. doi: 10.1002/hsr2.1670. PMID: 37920661; PMCID: PMC10618901.

108.                   Fazlollahi A, Zahmatyar M, Shamekh A, Motamedi A, Seyedi F, Seyedmirzaei H, Mousavi SE, Nejadghaderi SA, Sullman MJM, Kolahi AA, Arshi S, Safiri S. Electroencephalographic findings post-COVID-19 vaccination: A systematic review of case reports and case series. Rev Med Virol. 2023 Nov;33(6):e2484. doi: 10.1002/rmv.2484. Epub 2023 Oct 9. PMID: 37807809.

1.     Nejadghaderi, S.A., Rezaei, N. (2023). Health Crisis and Cancer Prevention: Friend or Foe. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_321-1

• Nejadghaderi SA. Personal hygiene and infectious diseases. Presented as concept map at the 2^nd International Congress on prevention strategies for healthcare-associated infections, Mashhad, Iran, April 2018


• Nejadghaderi SA, Razi S, Keshavarz-fathi M, Rezaei N. Immune checkpoint inhibition for pancreatic cancer. 4^th Universal Scientific Education and Research Network (USERN) Congress, Budapest, Hungary, November 2019 (Accepted Poster, Not Presented)


• Ansarinejad N, Nejadghaderi SA, Balasi J. Transitional cell carcinoma (TCC) of bladder with metastasis to lung and bones. 3^rd national congress on clinical case reports, Karaj, Iran, December 2019. (Poster Presentation)